Rajiv Dave
Coventry Health Care
CancerInternal medicineRadiologySurgeryOncologyUnivariate analysisProspective cohort studyCohort studyAxillaMastectomyAdjuvant therapyLymphSentinel lymph nodeBreast reconstructionCoronavirus disease 2019 (COVID-19)Radiation therapyFamily medicineBreast cancerGeneral surgeryMedicinePandemic
116Publications
14H-index
734Citations
Publications 50
Newest
#1A Dattani (University Hospitals Birmingham NHS Foundation Trust)
#2A Chauhan (University Hospitals Birmingham NHS Foundation Trust)
Last. A Messahel (Telford)
view all 4 authors...
Source
#1Hannah L Bromley (University of Manchester)
#2Rajiv DaveH-Index: 14
Last. James HarveyH-Index: 16
view all 14 authors...
Introduction New medical devices must have adequate research, such that outcomes are known, enabling patients to be consented with knowledge of the safety and efficacy of the device to be implanted. Device trials are challenging due to the learning curve and iterative assessment of best practice. This study is designed to pilot a national collaborative approach to medical device introduction by breast surgeons in the UK, using breast localisation devices as an exemplar. The aim is to develop an ...
Source
#1Hannah L Bromley (University of Manchester)
#2Rajiv Dave (University of Manchester)H-Index: 14
Last. Ashu Gandhi (MAHSC: Manchester Academic Health Science Centre)H-Index: 15
view all 6 authors...
Gynaecomastia is the commonest male breast complaint. Most cases are benign but the condition may signify a serious underlying illness. The challenge in primary care is to identify which patients with gynaecomastia are at greatest risk of pathological aetiology, so that they may be offered prompt specialty-appropriate referral and treatment. This article offers guidance on the assessment and management of patients with gynaecomastia, including when and why to refer to secondary care. Gynaecomast...
Source
#1Rajiv Dave (University of Manchester)H-Index: 14
#1RV Dave (University of Manchester)H-Index: 3
view all 22 authors...
The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. This was a national cohort study of patients with early BC undergoing multidisciplinary team (MDT)-guided treatment recommendations during the pandemic, designated ‘standard’ or ‘COVID-altered’, in the preoperative, operative and post-operative setting. Of 3776 patients (from 64 UK units) in the st...
Source
#1Rajiv Dave (University of Manchester)H-Index: 14
#2Shan Cheung (PHE: Public Health England)H-Index: 5
Last. Ashu Gandhi (University of Manchester)H-Index: 15
view all 6 authors...
BACKGROUND Women with screen-detected invasive breast cancer who have macrometastatic disease on axillary sentinel lymph node biopsy (SLNB) are usually offered either surgical axillary node clearance (ANC) or axillary radiotherapy. These treatments can lead to significant complications for patients. The aim of this study was to identify a group of patients who may not require completion ANC. METHODS Data from the NHS Breast Screening Programme between 1 April 2012 and 31 March 2017 were interrog...
Source
#1I Whitehead (RLUH: Royal Liverpool University Hospital)H-Index: 1
#1I Whitehead (RLUH: Royal Liverpool University Hospital)
Last. Stuart McIntosh ('QUB': Queen's University Belfast)H-Index: 18
view all 19 authors...
Background Neoadjuvant systemic therapy (NST) is increasingly used in the treatment of breast cancer, yet it is clear that there is significant geographical variation in its use in the UK. This study aimed to examine stated practice across UK breast units, in terms of indications for use, radiological monitoring, pathological reporting of treatment response, and post-treatment surgical management. Methods Multidisciplinary teams (MDTs) from all UK breast units were invited to participate in the ...
1 CitationsSource
#1Santosh Somasundaram (University Hospitals of Morecambe Bay NHS Foundation Trust)H-Index: 1
#2Shelley Potter (UoB: University of Bristol)H-Index: 17
Last. James Harvey (University of Manchester)H-Index: 16
view all 8 authors...
INTRODUCTION Breast conserving surgery of impalpable breast lesions requires safe and effective localisation techniques. Wire localisation has traditionally been used, but has limitations. Newer techniques are now being introduced to mitigate this. The iBRA-NET group aims to robustly evaluate these new techniques in well-designed prospective studies. We report the first phase of this evaluation, a survey to establish current practice and service provision of breast localisation techniques in the...
4 CitationsSource
#1Rajiv DaveH-Index: 14
#1Rajiv V. DaveH-Index: 1
Last. GB MannH-Index: 7
view all 7 authors...
Source
#1Rajiv DaveH-Index: 14
#1RV DaveH-Index: 3
Last. J. MurphyH-Index: 1
view all 8 authors...
BACKGROUND Prepectoral implant-based breast reconstruction with acellular dermal matrix has become an increasingly popular option for selected patients. There are no randomized data to demonstrate short- or long-term outcomes. Cohort studies to date have demonstrated safety, but risk factors for complications are unknown. METHODS This was a prospective cohort study of all patients undergoing prepectoral implant-based breast reconstruction between 2013 and 2019. Clinical factors and those related...
1 CitationsSource
#1Alona Courtney (Imperial College London)H-Index: 3
#2Rachel O'Connell (The Royal Marsden NHS Foundation Trust)H-Index: 9
Last. RV DaveH-Index: 1
view all 19 authors...
Abstract Introduction Approximately 55000 women in the United Kingdom are diagnosed with new breast cancer annually. Since emerging in December 2019, SARS-CoV-2 (coronavirus disease 2019, COVID-19) has become a global pandemic, affecting healthcare delivery worldwide. In response to the pandemic, multiple guidelines were issued to assist with rationalising breast cancer care. The primary aim of the B-MaP-C study is to audit and describe breast cancer management of patients newly diagnosed with b...
2 CitationsSource